Khatami H

References (2)

Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin - Hermansen_2007_Diabetes.Obes.Metab_9_733
Author(s) : Hermansen K , Kipnes M , Luo E , Fanurik D , Khatami H , Stein P
Ref : Diabetes Obes Metab , 9 :733 , 2007
Abstract : Hermansen_2007_Diabetes.Obes.Metab_9_733
ESTHER : Hermansen_2007_Diabetes.Obes.Metab_9_733
PubMedSearch : Hermansen_2007_Diabetes.Obes.Metab_9_733
PubMedID: 17593236

Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus - Raz_2006_Diabetologia_49_2564
Author(s) : Raz I , Hanefeld M , Xu L , Caria C , Williams-Herman D , Khatami H
Ref : Diabetologia , 49 :2564 , 2006
Abstract : Raz_2006_Diabetologia_49_2564
ESTHER : Raz_2006_Diabetologia_49_2564
PubMedSearch : Raz_2006_Diabetologia_49_2564
PubMedID: 17001471